JBT Marel Corporation (NYSE:JBTM) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of JBT Marel Corporation (NYSE:JBTM) have earned a consensus rating of “Moderate Buy” from the four analysts that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $174.6667.

Several analysts recently issued reports on the company. Zacks Research downgraded JBT Marel from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 28th. Wall Street Zen downgraded JBT Marel from a “buy” rating to a “hold” rating in a research report on Sunday, June 21st. Seaport Research Partners set a $165.00 target price on JBT Marel in a research note on Thursday, May 21st. Weiss Ratings downgraded JBT Marel from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, June 5th. Finally, Oppenheimer assumed coverage on JBT Marel in a research report on Thursday, May 21st. They set an “outperform” rating and a $175.00 price target on the stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in JBTM. Eurizon Capital SGR S.p.A. acquired a new stake in JBT Marel during the 4th quarter valued at $25,000. EverSource Wealth Advisors LLC acquired a new position in JBT Marel in the 2nd quarter worth $28,000. Parallel Advisors LLC boosted its position in JBT Marel by 1,211.8% in the 1st quarter. Parallel Advisors LLC now owns 223 shares of the company’s stock valued at $29,000 after buying an additional 206 shares during the last quarter. Northwestern Mutual Wealth Management Co. purchased a new position in JBT Marel in the 2nd quarter valued at about $29,000. Finally, Group One Trading LLC boosted its position in JBT Marel by 49.3% in the 3rd quarter. Group One Trading LLC now owns 218 shares of the company’s stock valued at $31,000 after buying an additional 72 shares during the last quarter. 98.92% of the stock is owned by institutional investors and hedge funds.

JBT Marel Price Performance

JBTM opened at $122.08 on Friday. JBT Marel has a 52-week low of $113.67 and a 52-week high of $170.19. The company has a 50 day moving average of $134.44 and a two-hundred day moving average of $139.04. The company has a market cap of $6.36 billion, a P/E ratio of 33.26, a P/E/G ratio of 1.30 and a beta of 0.94. The company has a quick ratio of 0.61, a current ratio of 1.24 and a debt-to-equity ratio of 0.37.

JBT Marel (NYSE:JBTM) last issued its earnings results on Monday, August 3rd. The company reported $1.95 EPS for the quarter, missing analysts’ consensus estimates of $2.02 by ($0.07). JBT Marel had a net margin of 4.89% and a return on equity of 8.75%. The business had revenue of $981.00 million during the quarter. JBT Marel has set its FY 2026 guidance at 7.850-8.350 EPS. On average, analysts expect that JBT Marel will post 8.14 earnings per share for the current year.

JBT Marel Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 9th. Stockholders of record on Tuesday, May 26th were paid a dividend of $0.10 per share. The ex-dividend date was Tuesday, May 26th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.3%. JBT Marel’s dividend payout ratio (DPR) is currently 10.90%.

JBT Marel Company Profile

JBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market.